Johnstone PA - Search Results

1

A surveillance, epidemiology, and end results registry analysis of prostate cancer modality time trends by age.

Terakedis BE, Rossi PJ, Liauw SL, Johnstone PA, Jani AB. Terakedis BE, et al. Among authors: johnstone pa. Am J Clin Oncol. 2010 Dec;33(6):619-23. doi: 10.1097/COC.0b013e3181c4c6e1. Am J Clin Oncol. 2010. PMID: 20051808

2

The fate of 10-year clinically recurrence-free survivors after definitive radiotherapy for T1-3N0M0 prostate cancer.

Johnstone PA, Powell CR, Riffenburgh R, Bethel KJ, Kane CJ. Johnstone PA, et al. Radiat Oncol Investig. 1998;6(2):103-8. doi: 10.1002/(SICI)1520-6823(1998)6:2<103::AID-ROI6>3.0.CO;2-1. Radiat Oncol Investig. 1998. PMID: 9572687

3

Quality of life in T1-3N0 prostate cancer patients treated with radiation therapy with minimum 10-year follow-up.

Johnstone PA, Gray C, Powell CR. Johnstone PA, et al. Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):833-8. doi: 10.1016/s0360-3016(99)00496-4. Int J Radiat Oncol Biol Phys. 2000. PMID: 10705003

4

Merkel cell carcinoma arising in the head and neck: optimizing therapy.

Lawenda BD, Thiringer JK, Foss RD, Johnstone PA. Lawenda BD, et al. Among authors: johnstone pa. Am J Clin Oncol. 2001 Feb;24(1):35-42. doi: 10.1097/00000421-200102000-00006. Am J Clin Oncol. 2001. PMID: 11232947 Review.

5

Initiation of salvage therapy for prostate cancer.

Johnstone PA, Booth R, Riffenburgh RH, Amling CL, Kane CJ, Moul JW. Johnstone PA, et al. Prostate Cancer Prostatic Dis. 2002;5(2):136-43. doi: 10.1038/sj.pcan.4500566. Prostate Cancer Prostatic Dis. 2002. PMID: 12497004

6

Palliative irradiation of the spleen.

McFarland JT, Kuzma C, Millard FE, Johnstone PA. McFarland JT, et al. Among authors: johnstone pa. Am J Clin Oncol. 2003 Apr;26(2):178-83. doi: 10.1097/00000421-200304000-00016. Am J Clin Oncol. 2003. PMID: 12714892

7

Survival of patients with untreated cervical carcinoma.

Adriano E, Jagoe JM, Harrison T, Riffenburgh RH, Johnstone PA. Adriano E, et al. Among authors: johnstone pa. Am J Clin Oncol. 2003 Aug;26(4):369-73. doi: 10.1097/01.COC.0000026909.73608.88. Am J Clin Oncol. 2003. PMID: 12902888 Review.

8

The 100-day PSA: usefulness as surrogate end point for biochemical disease-free survival after definitive radiotherapy of prostate cancer.

Johnstone PA, Williams SR, Riffenburgh RH. Johnstone PA, et al. Prostate Cancer Prostatic Dis. 2004;7(3):263-7. doi: 10.1038/sj.pcan.4500736. Prostate Cancer Prostatic Dis. 2004. PMID: 15289811

9

Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer.

Ludwig MS, Goodman M, Miller DL, Johnstone PA. Ludwig MS, et al. Among authors: johnstone pa. Chest. 2005 Sep;128(3):1545-50. doi: 10.1378/chest.128.3.1545. Chest. 2005. PMID: 16162756

10

Neuroblastoma in adults: Incidence and survival analysis based on SEER data.

Esiashvili N, Goodman M, Ward K, Marcus RB Jr, Johnstone PA. Esiashvili N, et al. Among authors: johnstone pa. Pediatr Blood Cancer. 2007 Jul;49(1):41-6. doi: 10.1002/pbc.20859. Pediatr Blood Cancer. 2007. PMID: 16628557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

295 results

Search Page

Filters